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PURPOSE: To compare the characteristics of tubercular vs. leukemic involvement of abdominopelvic lymph
nodes using multidetector computed tomography (CT).
MATERIALS AND METHODS: We retrospectively reviewed multidetector computed tomography features
including lymph node size, shape, enhancement patterns, and anatomical distribution, in 106 consecutive
patients with newly diagnosed, untreated tuberculosis (55 patients; 52%) or leukemia (51 patients; 48%). In
patients with leukemia, 32 (62.7%) had chronic lymphocytic leukemia, and 19 (37.3%) had acute leukemias; of
these, 10 (19.6%) had acute myeloid leukemia, and 9 (17.6%) had acute lymphocytic leukemia.
RESULTS: The lower para-aortic (30.9% for tuberculosis, 63.2% for acute leukemias and 87.5% for chronic
lymphocytic leukemia) and inguinal (9.1% for tuberculosis, 57.9% for acute leukemias and 53.1% for chronic
lymphocytic leukemia) lymph nodes were involved more frequently in the three types of leukemia than in
tuberculosis (both with p ,0.017). Tuberculosis showed peripheral enhancement, frequently with a
multilocular appearance, in 43 (78.2%) patients, whereas patients with leukemia (78.9% for acute myeloid
leukemia and acute lymphocytic leukemia, 87.5% for chronic lymphocytic leukemia) demonstrated
predominantly homogeneous enhancement (both with p ,0.017). For the diagnosis of tuberculosis, the
analysis showed that a peripheral enhancement pattern had a sensitivity of 78.2%, a specificity of 100%, and an
accuracy of 88.7%. For the diagnosis of leukemia, the analysis showed that a homogeneous enhancement
pattern was associated with a sensitivity of 84.3%, a specificity of 94.5%, and an accuracy of 89.6%.
CONCLUSION: Our findings indicate that the anatomical distribution and enhancement patterns of
lymphadenopathy seen on multidetector computed tomography are useful for differentiating between
untreated tuberculosis and leukemia of the abdominopelvic lymph nodes.
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& INTRODUCTION
According to the World Health Organization, tuberculosis
(TB) is the second highest cause of infection-related
mortality and was responsible for 1.4 million deaths in
2011 (1). TB remains a major global health challenge due to
HIV co-infection, multi-drug resistance, and immigration,
especially in many Asian and African countries (2,3).
Abdominal TB usually involves the lymph nodes, the
genitourinary tract, the peritoneal cavity and the gastro-
intestinal tract, with lymphadenopathy being its most
common manifestation (4,5). Leukemia also infiltrates
lymph nodes and may mimic some of the symptoms and
clinical signs of TB that involves the abdominopelvic lymph
nodes. In some cases, these two diseases present simulta-
neously or appear successively, which can complicate the
diagnosis (6-10). Distinguishing between these two entities
is essential for accurate diagnosis and prompt treatment.
Multidetector computed tomography (MDCT) has become
an ideal diagnostic tool for TB because of its high temporal
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and spatial resolution and its ability to generate multiplanar
reformation (MPR) images. Previously, we found that the
distribution and enhancement patterns obtained using MRI
or MDCT differed between TB and lymphomas involving
the abdominal lymph nodes. These tools were thus helpful
for differentiating between the two diseases (11,12).
However, there remains doubt as to whether such distribu-
tion and enhancement differences also exist between TB and
leukemias. To the best of our knowledge, no published
studies have compared TB and leukemia of the abdomino-
pelvic lymph nodes using MDCT (13-16). We therefore
conducted this study to investigate any potential differ-
ences, with the aim being to facilitate more timely and
effective treatments.
& MATERIALS AND METHODS
Subjects
The Institutional Research Board of our hospital approved
the study. Informed consent was obtained from all patients
and included information on the possibility of a reaction to
the MDCT contrast agent. We retrospectively reviewed 55
consecutive patients who visited our hospital from January
2008 to September 2013 with documented abdominal TB, as
well as 51 patients who had untreated leukemia involving
the abdominal and pelvic lymph nodes. All enrolled
patients underwent abdominal and pelvic contrast-
enhanced MDCT scanning. No patients had evidence of
other neoplastic diseases, opportunistic infections, liver
cirrhosis, or surgical history. Patients with treated leukemia
or who did not have a definitive TB diagnosis were
excluded.
The cohort of untreated TB patients included 21 women
and 34 men, with a mean age of 30.3 years (range, 14 to 77
years). Three patients were diagnosed with HIV co-infection.
Constitutional symptoms were as follows: vague abdominal
pain (n = 28), abdominal swelling (n = 21), low-grade fever
(n = 26), night sweats (n = 28), weight loss (n = 20), diarrhea
(n = 6), weakness (n = 17) and abdominal mass (n = 2).
Disease duration ranged from 2 weeks to 2 months. The final
diagnosis of TB was confirmed by bacteriological (n = 8) or
histopathological (n = 28) findings or the presence of proven
TB at extra-abdominal and extra-pelvic sites that had
improved after drug treatment for TB (n = 19).
The cohort of untreated leukemia patients included 14
women and 37 men, with a mean age of 50.9 years (range, 15
to 82 years). Ten patients were diagnosed with acute
myeloid leukemia (AML), 9 with acute lymphocytic
leukemia (ALL), and 32 with chronic lymphocytic leukemia
(CLL). The most frequent clinical signs and symptoms
in these patients were as follows: lymphadenopathy or
clinically palpable masses in the neck (n = 8); enlargement
of lymph nodes in more than one location (jaw, neck, axilla,
or groin) or throughout the body (n = 15); fever (n = 11);
vertigo (n = 8); weakness (n = 12); back pain (n = 6); and
bleeding tendency (n = 6). The diagnosis of leukemia was
made by bone marrow biopsy and flow cytometry (FCM) in
47 patients; in the remaining four patients, the diagnosis of
leukemia was made by performing a biopsy of the enlarged
lymph nodes and a routine blood test.
Scanning parameters
All included patients completed MDCT scanning within
2-3 days of diagnosis. In 43 patients, scanning was
performed with a Somatom Sensation 16 16-section scanner
(Siemens Medical Systems, Forchheim, Germany) with the
following parameters: 120 kV; 100 mAs; rotation time of
0.5 s; collimation of 16 mm 6 0.75 mm; pitch of 0.85;
thickness of 5 mm and gap of 2 mm. In 42 patients,
scanning was performed with a 64-detector-row CT system
(Brilliance 64, Philips Medical Systems, Eindhoven, the
Netherlands) with the following parameters: 120 kV;
145 mAs; rotation time of 0.42 s; collimation of 64 mm 6
0.625 mm; pitch of 0.891; thickness of 5 mm and gap of
2 mm. The remaining 21 patients were scanned using a
dual-source CT system (Somatom Definition; Siemens
Healthcare, Forchheim, Germany) in single-tube mode, with
the following parameters: 120 kV; 200 mAs; rotation time of
0.33 s; collimation of 24 mm 6 1.2 mm; pitch of 0.9;
thickness of 5 mm and gap of 2 mm. The patients were
asked to empty their bowels and drink 500–750 mL water 30
minutes before the scan. Each patient underwent non-
enhanced and enhanced scanning of the entire abdomen,
from the top of the diaphragm to the inferior margin of the
pubic symphysis. After initial non-enhanced scanning, all
patients received 80–85 mL of contrast agent (Iohexol,
300 mg iodine/mL; Beijing Beilu Pharmaceutical, Beijing,
China), which was injected using an automatic power
injector (Stellant D Dual Syringe, Medrad, Indianola, PA,
USA) at a rate of 1.8–2.2 mL/s, via a catheter that had been
placed in the antecubital vein. Contrast-enhanced images
were obtained after a 60-70 s delay.
Review of MDCT images
Two experienced radiologists (both professors, one with
25 years and the other with 30 years of experience in
abdominal imaging) who were blinded to the diagnosis
independently interpreted the continuous MDCT images on
a dedicated workstation (Syngo; Siemens Medical Systems,
Forchheim, Germany). Coronal and sagittal MPR images
were also generated using a soft-tissue reconstruction
algorithm to aid in the interpretation. The CT features of
the affected lymph nodes were recorded, including size,
shape, enhancement patterns, and anatomical distribution
on MDCT. Any discrepancies between the interpretations
were resolved by discussion to obtain a consensus decision.
Lymph nodes were observed in the following anatomic
regions: the greater omentum; the lesser omentum (includ-
ing the hepatogastric ligament, hepatoduodenal ligament,
hepatic hilus, and splenic hilus); the mesentery; the anterior
pararenal space (including the mesenteric root and the
peripancreatic region); the upper and lower para-aortic
regions (divided by the upper edge of L3); the internal iliac,
external iliac, and common iliac regions; and the inguinal
region. The short-axis diameter of each lymph node was
measured and compared with that of normal abdominal
lymph nodes as proposed by Dorfman et al. (17). Lymph
nodes that were larger than the normal size were recorded
as enlarged.
The enhancement patterns of the enlarged lymph nodes
were classified as homogeneous, peripheral, homogeneous
mixed with peripheral, or multilocular. Enhancement was
considered peripheral when thick, irregular, or thin
enhancement of the rim was seen. A combination of
homogeneous and peripheral enhancement was considered
when some enlarged lymph nodes showed homogeneous
enhancement, but other nodes at the same site showed
peripheral enhancement. A multilocular appearance was
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confirmed when more than three adjacent conglomerate
nodes showed peripheral enhancement and low central
attenuation; this was considered a subtype of peripheral
enhancement that could sometimes be seen in the two
enhancement patterns (12). We also observed extranodal
sites, such as the liver, the spleen, the kidney, the adrenal
gland and the abdominal wall.
Statistical analysis
All statistical analyses were performed using SPSS soft-
ware (version 20.0 for Windows, SPSS Inc., Chicago, IL,
USA). Categorical variables were expressed as numbers
(percentages). Comparisons of anatomical distributions and
enhancement patterns between the TB group and the two
leukemia groups were performed using the x2 test or
Fisher’s exact test. Bonferroni corrections were performed
for multiple pairwise comparisons by adjusting the sig-
nificance level (a). Continuous variables were presented as
the mean¡SD. The comparison of lymph node size between
the TB group and the leukemia group was performed using
Student’s t-test. A two-tailed P-value ,0.05 was considered
to be statistically significant.
& RESULTS
MDCT manifestations of untreated tubercular
lymphadenopathy
Enlarged lymph nodes in the TB groupwere circular, ovoid
and irregular. The diameter of the lymph nodes associated
with TB was 1.23¡0.56 cm. TB mainly affected lymph nodes
in the lesser omentum (60.0%), the mesentery (65.5%), the
anterior pararenal space (63.6%) and the upper para-aortic
regions (60.0%) (Table 1). Calcification within the nodes was
observed on unenhanced CT images in three patients.
The TB group demonstrated three enhancement patterns:
peripheral (n = 43, 78.2%) (Figure 1), homogeneous (n = 3,
5.5%), and homogeneous mixed with peripheral (n = 9,
16.4%). Of the 52 patients with peripheral enhancement or
homogeneous mixed with peripheral enhancement, 23
(41.8%) had a multilocular appearance (Table 2, Figure 1).
One patient (1.8%) had hepatomegaly; two (3.6%)
exhibited sporadic, peripherally enhancing lesions. Ad-
ditionally, five patients (9.1%) had splenomegaly, eight
(14.5%) had scattered peripherally enhancing lesions
(Figure 1), and five (9.1%) had unilateral renal involvement.
Ascites was detected in seven cases (12.7%), and 29 cases
(52.7%) presented with thickening of the parietal perito-
neum, the mesentery, and the greater and lesser omentum.
Fifteen patients (27.3%) showed circumferential wall thick-
ening in the bowel, and one (1.8%) displayed gastric wall
thickening in the distal body. In addition, three patients
(5.5%) had psoas abscesses.
MDCT manifestations of untreated leukemia
Analysis revealed that the enlarged lymph nodes were
round or ovoid and that some were fused into irregular
masses. Their mean diameter was 1.45¡0.67 cm. AML and
ALL mainly affected lymph nodes in the upper para-aortic
region (73.7%), the lower para-aortic region (63.2%), and the
groin (57.9%). CLL mainly affected the lymph nodes in the
lesser omentum (87.5%), the mesentery (59.4%), the anterior
pararenal space (81.3%), the upper and lower para-aortic
regions (90.6% and 87.5%, respectively), the external iliac
region (53.1%), and the inguinal region (53.1%) (Table 1). No
calcifications were identified in the lymph nodes of this
cohort of patients.
In patients with AML and ALL, the enlarged lymph
nodes on CT showed two enhancement patterns: 15 patients
(78.9%) had homogeneous enhancement, whereas four
patients (21.1%) had a combination of homogeneous and
peripheral enhancement. In patients with CLL, the enlarged
lymph nodes on CT also showed two enhancement patterns.
In this case, 28 patients (87.5%) had homogeneous enhance-
ment (Figure 2), and four patients (12.5%) had a combina-
tion of homogeneous and peripheral enhancement (Table 2).
In the acute leukemia groups (AML and ALL), nine
patients (47.4%) had homogeneous hepatomegaly, one
(5.3%) had multiple low-density lesions, and nine (47.4%)
had splenomegaly; of these, three (15.8%) had low-density
lesions. In addition, six patients (31.6%) had simultaneous
hepatomegaly and splenomegaly. Mesenteric thickening
was observed in one patient (5.3%). One patient (5.3%)
had bilateral adrenal gland involvement, one (5.3%) had a
low-density lesion in the kidney, and two (10.5%) showed
peritoneal thickening and mesenteric thickening. In the CLL
group, five patients (15.6%) had homogeneous hepatome-
galy, and one (3.1%) had multiple low-density lesions.
Twenty-four patients (75.0%) had splenomegaly, of whom
three (9.4%) had low-density lesions. Five patients (15.6%)
with CLL had simultaneous hepatomegaly and splenome-
galy, and one (3.1%) showed mesenteric thickening.
Table 1 - Comparison of anatomic distribution between tuberculosis and leukemias.
Site TB (n= 55) Leukemias P value
AL (n= 19) CLL (n= 32) TB vs AL TB vs CLL
Greater omentum 5(9.1) 0(0) 4(12.5) 0.319 0.72
Lesser omentum 33(60.0) 8(42.1) 28(87.5) 0.176 0.007
Mesentery 36(65.5) 5(26.3) 19(59.4) 0.003 0.571
Anterior pararenal space 35(63.6) 9(47.4) 26(81.3) 0.213 0.084
Upper paraaortic region 33(60.0) 14(73.7) 29(90.6) 0.285 0.002
Lower paraaortic region 17(30.9) 12(63.2) 28(87.5) 0.013 0
Common iliac 16(29.1) 6(31.6) 15(46.9) 0.838 0.095
External iliac 8(14.5) 5(26.3) 17(53.1) 0.298 0
Internal iliac 3(5.5) 2(10.5) 7(21.9) 0.598 0.034
Groin 5(9.1) 11(57.9) 17(53.1) 0 0
The numbers in parentheses are percentages. AL = acute leukemias including acute myeloid leukemia and acute lymphocytic leukemia, CLL = chronic
lymphocytic leukemia, TB = tuberculosis, NS = not significant.
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Comparison between untreated TB and leukemia
The diameter of leukemia lymph nodes was larger than
those involved with abdominal TB (p ,0.01). There was also
a statistically significant difference in the anatomical
distribution of lymph nodes (p ,0.017, Table 1), with the
three types of leukemia more frequently involving the lower
para-aortic region and the groin.
Peripheral and multilocular enhancement were observed
more frequently in patients with TB than in patients with
leukemia (p ,0.01); patients with leukemia were more likely
to have homogeneous enhancement (p ,0.01, Table 2).
In cases of TB with a peripheral enhancement pattern, the
following measurements were observed: sensitivity of 78.2%
(43/55), specificity of 100% (51/51), accuracy of 88.7% (94/
106), positive predictive value of 100% (43/43), and negative
predictive value of 81.0% (51/63). Similarly, in leukemic
patients with a homogeneous enhancement pattern, the
following measurements were obtained: sensitivity of 84.3%
(43/51), specificity of 94.5% (52/55), accuracy of 89.6% (95/
106), positive predictive value of 93.5% (43/46), and
negative predictive value of 86.7% (52/60).
& DISCUSSION
TB, the second most common life-threatening infectious
disease, is usually caused by Mycobacterium tuberculosis.
Although TB usually affects the lungs, it may cause disease
in almost every part of the body, with abdominal TB
representing the most common extrapulmonary form (5).
Abdominal TB may involve a variety of organs and tissues
in the abdomen and may thus mimic many different
diseases. The early and accurate diagnosis of this form of
TB is therefore especially important. Lymphadenopathy is
the most common manifestation of abdominal TB, and
sometimes it is the only symptom of the disease (4).
Although biopsy is considered the gold standard for the
diagnosis of lymphadenopathy, it is invasive and time-
consuming. In contrast, MDCT has the advantage of
displaying a broad range of information, including details
of specific organ and tissue involvement, in a single
examination. This may assist in determining the exact
location of an enlarged node before its surgical excision and
in evaluating the extent of the disease. In addition, the
imaging features of extranodal organs may help differenti-
ate TB from other diseases.
Tuberculous abdominal lymphadenopathy can develop
via three main routes. The most common route is the
ingestion of infected material containing tubercle bacilli,
such as sputum or milk. The second route is the
hematogenous spread of bacteria from a distant infection,
usually the lungs, and the third route is the direct extension
from the serosa of adjacent, involved tissues (14). In the first
method of transmission, the bacilli in the lymphoid tissue of
the intestinal submucosal layer form epithelioid tubercles.
These tubercles drain into the lymphatics of the ileocecum,
jejunum, ileum, and the right side of the colon and then to
the peripancreatic and superior mesenteric lymph nodes
(the anterior pararenal space) at the level of L1, then
subsequently to the intestinal trunk, and finally to the
cisterna chyli (12,18). Gastric and duodenal involvement of
TB is not common, and the bacilli are able to drain into the
hepatic hilum, the hepatogastric and hepatoduodenal
ligaments, and the peripancreatic region. The lymphatics
of the left side of the colon drain to the inferior mesenteric
lymph nodes at the level of L3. This route is rarely involved
in the dissemination of bacilli; therefore, involvement of the
lower para-aortic lymph nodes is rare (12). The inguinal
lymph nodes collect lymph mainly from the lower limbs,
and they are rarely involved in abdominal TB. In our study,
the predominant anatomic distribution of TB was in the
lesser omentum (60.0%), the mesentery (65.5%), the anterior
pararenal space (63.6%) and the upper para-aortic regions
(60.0%), with the exception of the lower para-aortic region
(30.9%). This finding is consistent with the known lympha-
tic drainage routes.
Figure 1 - A 19-year-old female with abdominopelvic and splenic
tuberculosis. A: A contrast-enhanced image shows peripheral
enhancement of enlarged lymph nodes in the splenic hilum (the
lesser omentum; star) and sporadic peripheral enhancement
lesions in the spleen (arrow). B: A contrast-enhanced image
shows peripheral enhancement of enlarged lymph nodes in the
anterior pararenal space (the mesenteric root; arrow) and the
upper para-aortic region (arrowhead). The descending duode-
num can be recognized by its mucosal folds (white star). The
adjacent intestinal tract shows homogeneous density (black star).
C: The enlarged lymph nodes demonstrate peripheral enhance-
ment with a multilocular appearance in the mesentery (arrow).
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TB-related lymph node enlargement has different stages,
which result in different enhancement patterns. In stage
one, the lymphoid tissues proliferate and form non-necrotic
tubercles and caseating granulomas. In these cases, CT of
the lymph nodes shows homogenous enhancement patterns
both before and after contrast media injection. In the
following stage, the caseating tissues in the center of the
lymph nodes display necrosis with intact capsules. Thus,
peripheral enhancement can be observed, but the caseating
necrosis in the center does not enhance, and the peripheral
inflammatory lymphatic tissues show rim enhancement.
Once capsular destruction has taken place, periadenitis
occurs and adjacent lymph nodes fuse. At this stage,
multilocular enhancement is observed. Finally, in the
healing stage, lymph node fibrosis and calcification occur.
In this stage, calcification of the lymph nodes on plain CT
images is sometimes observed (14,18). In our study, 78.2% of
cases showed peripheral enhancement, 16.4% showed a
combination of homogeneous and peripheral enhancement,
41.8% had a multilocular appearance, and 5.5% showed
homogeneous enhancement. Our finding that peripheral
enhancement was most frequently observed is consistent
with previous studies (13,19,20). In the diagnosis of TB, a
peripheral enhancement pattern was associated with a high
diagnostic specificity and positive predictive value. All
infected nodes measured in our study were less than 4 cm
in diameter, consistent with pathologically self-limiting
growth.
Leukemia is a group of diseases characterized by the
clonal proliferation of abnormal leukocytes presenting in
hematopoietic tissues and other organs. Lymphadenopathy
is commonly observed in leukemia and is associated with an
unfavorable prognosis (21-23). Leukemia is a systemic
disease that can cause generalized lymphadenopathy invol-
ving more than two noncontiguous regions (23). In our
study, the lower para-aortic region and the inguinal lymph
nodes were involved more frequently in the three types of
leukemias than in TB (p ,0.017). The main anatomic sites of
involvement in patients with AML and ALL were the upper
para-aortic region, the lower para-aortic region, and the
groin. In patients with CLL, the lymph nodes in the lesser
omentum, the mesentery, the anterior pararenal space, the
upper and lower para-aortic regions, the external iliac
region, and the inguinal region were more frequently
involved. No calcifications were identified in the cohort of
leukemia patients. In TB, calcification occurs in the last
phase of recovery from inflammation. Leukemic lympha-
denopathy is an unlimited clonal proliferation of abnormal
leukocytes in lymph nodes with no limitation. These nodes
provide an environment that favors the growth and survival
of malignant lymphocytes (24), which seems less likely to
cause calcification. However, further explanation may be
Table 2 - Comparison of enhancement patterns between tuberculosis and leukemias.
Enhancement pattern TB (n= 55) Leukemias P
AL (n= 19) CLL (n= 32) TB vs AL TB vs CLL
Peripheral 43(78.2) 0(0) 0(0) 0 0
Homogeneous 3(5.5) 15(78.9) 27(84.4) 0 0
Homogeneous mixed with peripheral 9(16.4) 4(21.1) 5(15.6) 0.729 0.928
Multilocular 23(41.8) 0(0) 0(0) 0.001 0
The numbers in parentheses are percentages. AL = acute leukemias including acute myeloid leukemia and acute lymphocytic leukemia, CLL = chronic
lymphocytic leukemia, TB = tuberculosis, NS = not significant.
Figure 2 - An 84-year-old man with chronic lymphocytic
leukemia. A: An enhanced CT image shows homogeneous
enhancement of enlarged lymph nodes in the lesser omentum
(star) and the upper para-aortic region (arrowhead). B: A
contrast-enhanced image shows homogeneous enhancement
of lymph nodes in the lower para-aortic region (star) and the
mesentery (arrow). C: The enlarged lymph nodes show homo-
geneous enhancement in the external iliac (arrow) and inguinal
regions (star).
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aided by pathophysiologic investigation of this process.
Two enhancement patterns, homogeneous and homoge-
neous mixed with peripheral, were found in leukemia
patients, with the former pattern accounting for the majority
(78.9% for acute leukemias and 87.5% for CLL). Intra-nodal
necrosis was associated with a heterogeneous enhancement
pattern. For the diagnosis of leukemia, a homogenous
enhancement pattern provided both high diagnostic speci-
ficity and positive predictive values. Lymph node size
reflects a balance between cell proliferation and cell death.
In leukemia, lymph nodes are generally infiltrated by
malignant cells because this location favors their growth
and survival and prevents apoptosis (25). In our study,
lymph nodes associated with leukemia were larger than
those associated with TB (p ,0.01).
Enlarged lymph nodes that display a peripheral enhance-
ment pattern also can be observed in other diseases, such as
metastatic cancer, Whipple’s disease and lymphoma. In
metastatic malignancies arising from the testicles, the
ovaries or the gastrointestinal tract, a similar pattern is also
seen (18). With the primary tumor location and different cell
type, a metastatic malignancy can be easily diagnosed. The
different treatments adopted for different tumors may also
affect their appearance on MDCT. Moreover, the main
anatomic distribution of lymph nodes is dependent on
lymphatic drainage. Whipple’s disease is a systemic
infectious disorder that presents with a wide array of
symptoms, including migratory arthralgias or arthritis.
Symptoms related to nervous system involvement are
common, and polymerase chain reaction testing usually is
employed to confirm the disease. In some cases, invasive
biopsy of the involved tissue (usually a duodenal biopsy) is
recommended for a definitive diagnosis (26). A rim-
enhancing pattern of lymph nodes in untreated lymphoma
also can be observed in MDCT scanning but is rare. After
treatment, a rim-enhancing pattern is more commonly
observed. According to the study of Shao et al. (11), only
6.9% of lymph nodes show peripheral enhancement in
untreated lymphoma. Furthermore, Shao et al. also reported
that a homogeneous enhancement pattern can assist in the
differential diagnosis of lymphoma and TB, as it has a
sensitivity of 69% and a specificity of 96.4%. Further
investigations will be required regarding the comparison
of CT findings between leukemia and lymphoma of the
abdominal and pelvic lymph nodes.
A notable limitation of this study was that in four patients
leukemia was not confirmed using bone marrow biopsy and
FCM. However, in these patients, the diagnosis was made
by lymph node biopsy and blood tests, thereby minimizing
this shortcoming. Lymphadenopathy is also observed in
chronic myeloid leukemia. However, according to our
inclusion criteria that all patients underwent abdominal
and pelvic contrast-enhanced MDCT scanning, no such
cases were included in this study.
Our study has shown that MDCT can help to differentiate
between untreated abdominal TB and leukemia, based on
the anatomical distribution and enhancement patterns of
lymph nodes. Abdominal TB mainly involved lymph nodes
in the mesentery, the anterior pararenal space, the upper
para-aortic regions and the lesser omentum. In contrast, the
lower para-aortic nodes and the groin lymph nodes were
predominantly involved in leukemia. Significant differences
in the lymph node enhancement patterns were also
observed. In particular, TB lymphadenopathy frequently
showed peripheral enhancement with a multilocular
appearance, whereas homogeneous enhancement was
observed more commonly in leukemia.
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